PRPH and neuroblastoma: In accordance with this finding, a genome-wide methylation screening study with neuroblastoma patient samples reported that enhanced promotor methylation of the PRPH gene (which should result in less PRPH expression) is associated with at least one classical risk factor for an unfavorable prognosis (age, stage or MYCN status)41.